会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • BETA-LACTAMS FOR TREATMENT OF CNS DISORDERS
    • 用于治疗CNS疾病的BETA-LACTAMS
    • WO2005049600A1
    • 2005-06-02
    • PCT/EP2004/012772
    • 2004-11-10
    • GLAXO GROUP LIMITEDALVARO, GiuseppeDI FABIO, RomanoGIOVANNINI, RiccardoPAIO, AlfredoTRANQUILLINI, Maria, ElviraMATTIOLI, Lucia
    • ALVARO, GiuseppeDI FABIO, RomanoGIOVANNINI, RiccardoPAIO, AlfredoTRANQUILLINI, Maria, ElviraMATTIOLI, Lucia
    • C07D401/04
    • C07D401/04
    • The present invention relates to novel compounds of formula (I) wherein ---- represents a single or a double bond; R represents a radical selected from formulae i), ii), iii) and iv) in which R 1 is halogen, cyano, C 1-4 alkyl, C 1-4 alkoxy, trifluoromethyl or trifluoromethoxy and p is zero or an integer from 1 to 3; R 2 represents hydrogen or C 1-4 alkyl; R 3 represents hydrogen, hydroxy or C 1-4 alkyl; R 4 represents hydrogen or R 4 together with R 3 represents =0 or =CH 2 ; R 5 represents phenyl, naphthyl, a 9 to 10 membered fused bicyclic heterocyclic group or a 5 or 6 membered heteroaryl group, wherein said groups are optionally substituted by 1 to 3 groups independently selected from trifluoromethyl, C 1-4 alkyl, hydroxy, cyano, C 1-4 alkoxy, trifluoromethoxy, halogen or S(O)qC 1-4 alkyl; R 6 and R 7 independently represent hydrogen, cyano, C 1-4 alkyl; R 8 is (CH 2 )rR 10 ; R 9 represents hydrogen, halogen, C 3-7 cycloalkyl, hydroxy, nitro, cyano or C 1-4 alkyl optionally substituted by one or two groups selected from halogen, cyano, hydroxy or C 1-4 alkoxy; R 10 represents hydrogen or C 3-7 cycloalkyl; n represents 1 or 2; q is 0, 1 or 2; r is 0 or an integer from 1 to 4; or a pharmaceutically acceptable salt or a solvate thereof, process for their preparation and their use in the treatment of conditions mediated by tackykinins and/or by selective inhibition of the serotonin reuptake transporter protein.
    • 本发明涉及式(I)的新化合物,其中----表示单键或双键; R表示选自式i),ii),iii)和iv)中的基团,其中R 1为卤素,氰基,C 1-4烷基,C 1-4烷氧基,三氟甲基或三氟甲氧基,p为0或1至3的整数 ; R2代表氢或C1-4烷基; R3表示氢,羟基或C1-4烷基; R4表示氢或R4,R3表示= 0或= CH2; R5表示苯基,萘基,9至10元稠合双环杂环基或5或6元杂芳基,其中所述基团任选被1至3个独立地选自三氟甲基,C 1-4烷基,羟基,氰基,C 1-4烷氧基,三氟甲氧基,卤素或S(O)qC 1-4烷基; R6和R7独立地表示氢,氰基,C1-4烷基; R8为(CH2)rR10; R9代表氢,卤素,C3-7环烷基,羟基,硝基,氰基或任选被一个或两个选自卤素,氰基,羟基或C 1-4烷氧基的基团取代的C 1-4烷基; R 10表示氢或C 3-7环烷基; n表示1或2; q是0,1或2; r为0或1至4的整数; 或其药学上可接受的盐或溶剂合物,其制备方法及其用于治疗由粘蛋白介导的病症和/或通过选择性抑制5-羟色胺再摄取转运蛋白。